Navigation Links
Renowned Scientists Join Cure Alzheimer’s Fund’s Search for Alzheimer’s Therapies
Date:11/19/2013

Boston, MA (PRWEB) November 19, 2013

Adding to its impressive roster of many of the nation’s leading scientists, the Cure Alzheimer’s Fund Research Consortium is pleased to announce its two newest members, Eric Schadt, Ph.D., and Rick Huganir, Ph.D.

The Research Consortium develops and updates a "roadmap for research" for the most effective and efficient route to slowing, stopping and/or reversing Alzheimer’s disease, the most common form of dementia. Members research their own projects and recruit others whose work will hasten the development of effective therapies.

"We are very excited about the prospect of working with these two truly outstanding scientists in our quest to conquer Alzheimer’s disease," said Dr. Rudolph E. Tanzi, consortium chair and director of the Genetics and Aging Research Unit at Harvard Medical School.

Eric Schadt, Ph.D., is director of the Icahn Institute for Genomics and Multiscale Biology and chair of the Department of Genetics and Genomics Sciences. He is also a professor of genomics at the Icahn School of Medicine at Mount Sinai.

Dr. Schadt is an expert in generating and integrating large-scale sequence variation, molecular profiling and using clinical data from disease populations to construct molecular networks that define disease states and link molecular biology to physiology. Dr. Schadt’s research has provided key insights into what is needed to master large-scale, diverse data collection to better understand diseases and to improve treatment options. He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries related to the genetic basis of such common human disorders as diabetes, obesity and Alzheimer’s disease.

Richard L. Huganir, Ph.D., is a professor and director of the Solomon H. Snyder Department of Neuroscience and an investigator with Howard Hughes Medical Institute.

Dr. Huganir’s groundbreaking research on the mechanisms of communication between neurons in the brain earned him great recognition in the neuroscience community. He also has received the Young Investigator Award and the Julius Axelrod Award from the Society for Neuroscience. He has published more than 200 papers in peer-reviewed journals.

Cure Alzheimer’s Fund is governed by a board of directors, administered by a small, full-time staff and guided scientifically by a Research Consortium and Scientific Advisory Board. Cure Alzheimer’s Fund™ is a 501(c)(3) public charity. The fund has supported 77 projects in 51 laboratories of leading Alzheimer’s researchers in the United States and abroad.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11344632.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Renowned Dermatology Practice in San Diego Announces Launch of New Liposuction Website
2. As a Renowned Cosmetic Surgeon in Southern California, Dr. Kathy Gohar Introduces New Anti-Aging Procedures
3. Cheap Ball Gown Wedding Dresses Offered By The Renowned Dress Manufacturer, OgotoShop.com
4. Renowned Pro Boxer Tracy Patterson to Provide Expert Boxing Training Commentary in Art of Boxing Magazine
5. Renowned Woodland Hills Dentist Announces Open Slots for Complimentary Consultations
6. Renowned Creighton University Professor Named President-Elect of the American Society of Bioethics and Humanities
7. Renowned Dentist from Around The Corner Dental Health Spa Unveils Why His Office in Woodlands Hills is the Best Choice for Dental Implants
8. Reputed and Renowned Ecommerce Expert, Shopping Cart Elite Proclaims New Features to Their Website
9. Renowned Digestive Health Expert, Brenda Watson, Returns to Public Television with 2 Eye-Opening Specials
10. World-Renowned Autism Expert Dr. Doreen Granpeesheh Presents Keynote Address at CARD Louisiana Autism Conference, August 24th in Baton Rouge
11. Renowned Shopping Cart Software Expert Shopping Cart Elite Officially Declares The Launch Of Mimousa.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... 2017 , ... Preora Diagnostics Inc. , a privately ... received two prestigious recognitions that acknowledge the promise of its PWS Nanoctyology platform ... been named a Top 100 Finalist for the 16th annual Chicago Innovation Awards ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that specializes ... to the athletic wear market with the launch of their FlipBelt Crops. , The ... essentials securely at their fingertips while at the gym, on the trail, or on-the-go. ...
(Date:9/21/2017)... CO (PRWEB) , ... September 21, 2017 , ... ... Interview of the Month, Lewis and Clark College Emeritus Professor of Education Gregory ... Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and ...
(Date:9/20/2017)... Virginia (PRWEB) , ... September 20, 2017 , ... ... Flex Pure Clinical Plus Coating System for clients that rely on safety and ... the growth of microorganisms. , Silver has been used for centuries for its ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Doctors on ... to their qualified network of medical professionals working on a personal injury lien basis. ... Spine Surgery Inc brings these esteemed doctors’ vast experience with orthopedic injuries to patients ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/6/2017)... 6, 2017 Eli Lilly and Company (NYSE: ... new data for galcanezumab and lasmiditan, two investigational treatments ... Headache Society (IHC) taking place Sept. 7-10 in ... highlight new, long-term data from an open-label study evaluating ... (120 mg and 240 mg) for the prevention of ...
Breaking Medicine Technology: